StockData
EVHNYSEServices-Management ServicesFiscal year ends December 31

Evolent Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.48−0.09 (-1.97%)

Close on Oct 19, 2026

Market cap
$504.19M
P/E (TTM)
–
Dividend yield
–

About Evolent Health

Services-Management Services, SIC 8741

Evolent coordinates healthcare for individuals with complex conditions, including cardiovascular disease, cancer, and musculoskeletal disorders. The company operates through a single reportable segment and delivers two primary offerings: specialty care management services and administrative services. Its specialty care management platform assists in clinical decision-making, establishes provider networks, and develops evidence-based treatment pathways. Its administrative services provide health plan operations, risk management, pharmacy benefit management, and analytics supported by its proprietary technology platform. Evolent serves healthcare payers, health plans, and risk-bearing entities, while supporting affiliated medical providers who deliver patient care.

Geographically, the company markets and sells its solutions to healthcare payers and medical providers throughout the United States. Its operations reach regional and national health plans across Medicare, Medicaid, and commercial populations. The provided report does not disclose specific facility counts, physical office locations, or the location of its corporate headquarters.

Summary of the business section of Evolent Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Evolent Health, Inc.
Founded
2011
Headquarters
Arlington, VA
Address
1812 North Moore St, Suite 1705 22209
Phone
(571) 389-6000
Employees
4,200, Dec 31, 2025
Industry
Services-Management Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, McLean, VA

Stock & identifiers

Ticker
EVH
Exchange
NYSE
Shares outstanding
113M, Aug 1, 2026
Public float
$1.30B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1628908
CUSIP
30050B101
ISIN
US30050B1017
LEI
549300CZOCFHQ2BBTR11
EIN
32-0454912

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Seth BlackleyChief Executive Officer, Director1,272,767
Daniel Joseph McCarthyPRESIDENT655,133
Jonathan WeinbergGeneral Counsel287,567
Aammaad ShamsChief Accounting Officer95,637
Mario RamosChief Financial Officer0
John Paul JohnsonChief Financial Officer309,245
Emily Ann RaffertyChief Operating Officer132,561
Brendan B. SpringstubbDirector99,917
Russell Monroe GlassDirector83,393
Peter J. GruaDirector123,743
Craig A. BarbaroshDirector95,031
Shawn M. GuertinDirector63,075
Richard M. JelinekDirector107,533
Kim KeckDirector102,597
Jill D. SmithDirector64,233
Toyin AjayiDirector75,170
Cheryl ScottDirector73,476
Diane HolderDirector70,584

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$14.24M$2.58M$5.01M$25$99
FY2024$11.14M-$9.30M$4.07M$70$81
FY2024
Seth Blackley
$11.14M-$9.30M$4.07M$70$81
FY2023$8.93M$20.11M$3.19M$206$82
FY2023
Seth Blackley
$8.93M$20.11M$3.19M$206$82
FY2022$7.73M$11.80M$2.51M$175$77

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of February 16, 2026, we had approximately 4,200 global employees.”

Corporate history

Events identified from SEC filings